Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;13(4):471-7.
doi: 10.1097/MCO.0b013e32833a558d.

Genetics of type 2 diabetes

Galina Smushkin  1 , Adrian Vella
Affiliations
Review

Genetics of type 2 diabetes

Galina Smushkin et al. Curr Opin Clin Nutr Metab Care. 2010 Jul.

Abstract

Purpose of review: To provide an overview of the genetics of type 2 diabetes in the context of recent progress in the understanding of the genetic architecture of the disease and its applicability to the pathogenesis of the disease as well as efforts to individualize therapy in type 2 diabetes. Efforts are underway to understand how these loci alter measurable physiologic processes in nondiabetic humans. However, it is important to understand the potential pitfalls in such studies and the limitations underlying measurement of insulin secretion and action using qualitative methodologies.

Recent findings: The availability of large population-based cohorts and the ease with which large numbers of common genetic variants can be genotyped has enabled the discovery of multiple loci and pathways associated with type 2 diabetes. Recent efforts examining quantitative traits such as fasting glucose concentrations have led to the discovery of other genes likely to be important in the development of diabetes.

Summary: The past 4 years have witnessed a significant increase in our understanding of genetic predisposition to type 2 diabetes. Hopefully more progress will be made in applying this knowledge to the pathophysiology of type 2 diabetes in the coming years.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

References

    1. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev. 1998 Aug;19(4):477–90. - PubMed
    1. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, et al. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 2006 Dec;55(12):3536–49. - PubMed
    1. Dinneen SF, Maldonado D, 3rd, Leibson CL, Klee GG, Li H, Melton LJ, 3rd, et al. Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care. 1998 Sep;21(9):1408–13. - PubMed
    1. Stolerman ES, Florez JC. Genomics of type 2 diabetes mellitus: implications for the clinician. Nature reviews. 2009 Aug;5(8):429–36. A comprehensive review of common genetic variation and association with type 2 diabetes. - PubMed
    1. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010 Feb;42(2):105–16. This study identified 9 novel loci (out of a total of 16) which alter fasting glucose concentration. Five of these loci also confer risk of type 2 diabetes. - PMC - PubMed

Publication types